Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HIV protease inhibitors from Novartis

July 17, 1997

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

Roche rights to Viracept expanded

July 16, 1997

Genesys Pharma receives Canadian approval to commence phase I trial with antisense AIDS treatment

July 16, 1997

HIV protease inhibitor enters phase III pediatric trial

July 15, 1997

Takeda's fumagillin analogue for microsporidial infections in AIDS patients

July 14, 1997

Cel-Sci developing AIDS vaccine with broad activity

July 11, 1997

HIV-IG pharmacokinetics assessed in AIDS patients

July 11, 1997

DuPont Merck investigates new approach to potent HIV protease inhibitors

July 9, 1997

AIDS vaccine described by Takeda

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...